Edith Huland
Impact in
-
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
-
- Prostate Cancer Treatment and Research 30
- Prostate Cancer Diagnosis and Treatment 28
- Renal cell carcinoma treatment 11
- Oncology 27
- Cancer Immunotherapy and Biomarkers 22
- Co-authors
- Hartwig HulandHans HeinzerMarkus GraefenAlexander HaesePeter HammererJoachim NoldusRolf‐Peter HenkeHans Lilja
- Journals
- The Journal of Urology (28 papers)European Urology (8 papers)Journal of Cancer Research and Clinical Oncology (5 papers)The Prostate (3 papers)Urology (3 papers)
- Partner nations
- GermanyUnited StatesSweden
In The Last Decade
Edith Huland
86 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 84
- Pulmonary and Respiratory Medicine 851
- Immunology 324
- Urology 96
- Rheumatology 217
- Oncology 392
Countries citing papers authored by Edith Huland
This map shows the geographic impact of Edith Huland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edith Huland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edith Huland more than expected).
Fields of papers citing papers by Edith Huland
This network shows the impact of papers produced by Edith Huland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edith Huland. The network helps show where Edith Huland may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Edith Huland, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 15 | |
| 2 | 2003 | 8 | |
| 3 | 2002 | 10 | |
| 4 | 2002 | 6 | |
| 5 | 2001 | 21 | |
| 6 | 2001 | 57 | |
| 7 | 2001 | 30 | |
| 8 | 2000 | 8 | |
| 9 | 1999 | 2 | |
| 10 | 1999 | 1 | |
| 11 | 1998 | 42 | |
| 12 | 1997 | 8 | |
| 13 | 1997 | 47 | |
| 14 | 1997 | 6 | |
| 15 | 1995 | 1 | |
| 16 | 1995 | 6 | |
| 17 | 1994 | 37 | |
| 18 | 1988 | 0 | |
| 19 | 1988 | 2 | |
| 20 | Human transitional cell carcinoma in the NMRI-nu/nu mouse bladder: a new animal model for the in vivo use of monoclonal antibodies and cytotoxic agents. | 1986 | 3 |
About Edith Huland
Edith Huland is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Biotechnology and Immunology, having authored 90 papers that have together received 1.6k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (30 papers), Prostate Cancer Diagnosis and Treatment (28 papers), Bladder and Urothelial Cancer Treatments (28 papers), Cancer Immunotherapy and Biomarkers (22 papers), Urinary and Genital Oncology Studies (14 papers), Immunotherapy and Immune Responses (12 papers), Renal cell carcinoma treatment (11 papers) and Urologic and reproductive health conditions (8 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (851 citations), Immunology (324 citations), Urology (96 citations), Rheumatology (217 citations) and Oncology (392 citations). Edith Huland has collaborated with scholars based in Germany, United States and Sweden. Frequent co-authors include Hartwig Huland, Hans Heinzer, Markus Graefen, Alexander Haese, Peter Hammerer, Joachim Noldus, Rolf‐Peter Henke, Hans Lilja, S. Conrad and Michael R. Shurin. Their work appears in journals such as The Journal of Urology, European Urology, Journal of Cancer Research and Clinical Oncology, The Prostate and Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.